Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.7 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |